EUVIMEDEUVIMED entdecken
Crossref

Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment

Lang Li iD, Anastasia Ivanova

Statistics in Medicine · 2025

DOI: 10.1002/sim.70318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Lang Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Biomarkers, Clinical Trials as Topic, Randomized Controlled Trials as Topic. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We consider biomarker‐stratified trials that test the treatment effect in a targeted patient group, the biomarker positive subgroup, and in the overall population. If the biomarker negative subgroup is stopped for futility during the interim analysis the number of participants assigned can be increased. Optimal two‐stage designs are obtained using several optimality criteria. Recommendations are given on the best interim analysis timing, futility boundaries, α allocation between the two hypotheses and stage 2 sample size for the biomarker positive subgroup in case its complement, the biomarker negative subgroup, is stopped for futility in the interim analysis. This work is motivated by PrecISE, a two‐stage biomarker‐stratified clinical trial in patients with severe asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersClinical Trials as TopicRandomized Controlled Trials as TopicHumansAsthmaSample SizeResearch DesignComputer Simulation

Stichwörter der Autor:innen

adaptive enrichment designbiomarker positive subgroupbiomarker‐stratified trial

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID-Profile: Lang Li

Zitieren

APA

Li, L., & Ivanova, A. (2025). Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment. Statistics in Medicine. https://doi.org/10.1002/sim.70318

Vancouver

Li L, Ivanova A. Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment. Statistics in Medicine. 2025. doi:10.1002/sim.70318

BibTeX
@article{Li2025,
  author = {Li, Lang and Ivanova, Anastasia},
  title = {Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70318}
}
Kostenlos starten →